| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3252725 | F | Antiviral activity against Vaccinia virus infected in human KB cells assessed as inhibition of virus-induced cytopathic effect at 1 to 1000 ug/ml after 72 hrs | Vaccinia virus | 7 | ALA3244032 | organism-based format | Scientific Literature | |
| 2. | ALA3252726 | F | Antiviral activity against HSV1 infected in human KB cells assessed as inhibition of virus-induced cytopathic effect at 1 to 1000 ug/ml after 72 hrs | Human alphaherpesvirus 1 | 7 | ALA3244032 | organism-based format | Scientific Literature | |
| 3. | ALA3252727 | F | Antiviral activity against Parainfluenza virus type 3 infected in human KB cells assessed as inhibition of virus-induced cytopathic effect at 1 to 1000 ug/ml after 72 hrs | Human respirovirus 3 | 7 | ALA3244032 | organism-based format | Scientific Literature | |
| 4. | ALA3252728 | F | Antiviral activity against Rhinovirus type 13 infected in human KB cells assessed as inhibition of virus-induced cytopathic effect at 1 to 1000 ug/ml after 72 hrs | Human rhinovirus A13 | 7 | ALA3244032 | cell-based format | Scientific Literature | |
| 5. | ALA3252729 | F | Antiviral activity against Adenovirus type 3 infected in human KB cells assessed as inhibition of virus-induced cytopathic effect at 1 to 1000 ug/ml after 72 hrs | Human adenovirus 3 | 7 | ALA3244032 | cell-based format | Scientific Literature | |
| 6. | ALA3252730 | T | Toxicity in Swiss mouse infected with Influenza A2 virus Japan 305 assessed as survival at 75 mg/kg/day, po bid administered for 9 days started at 4 hrs prior to infection | Mus musculus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 7. | ALA3252731 | T | Toxicity in Swiss mouse infected with Influenza B virus Lee assessed as survival at 75 mg/kg/day, ip bid administered for 9 days started at 4 hrs prior to infection | Mus musculus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 8. | ALA3252732 | T | Toxicity in Swiss mouse infected with Murine hepatitis virus Friend-Braunsteiner assessed as survival at 75 mg/kg/day, ip bid administered for 8 days started at 2 hrs prior to infection | Mus musculus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 9. | ALA3252733 | T | Toxicity in Swiss mouse infected with Murine hepatitis virus Friend-Braunsteiner assessed as survival at 37.5 mg/kg/day, ip bid administered for 8 days started at 2 hrs prior to infection | Mus musculus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 10. | ALA3252734 | T | Toxicity in Swiss mouse infected with Murine hepatitis virus Friend-Braunsteiner assessed as survival at 18.8 mg/kg/day, ip bid administered for 8 days started at 2 hrs prior to infection | Mus musculus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 11. | ALA3252735 | F | Antiviral activity against Influenza A2 virus Japan 305 infected in Swiss mouse assessed as survival at 75 mg/kg/day, po bid administered for 9 days relative to control | Influenza A virus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 12. | ALA3252736 | F | Antiviral activity against Influenza B virus Lee infected in Swiss mouse assessed as survival at 75 mg/kg/day, ip bid administered for 9 days relative to control | Influenza B virus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 13. | ALA3254578 | F | Antiviral activity against Murine hepatitis virus Friend-Braunsteiner infected in Swiss mouse assessed as survival at 18.8 to 75 mg/kg/day, ip bid administered for 8 days relative to control | Murine hepatitis virus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 14. | ALA3254579 | F | Antiviral activity against Influenza A2 virus Japan 305 infected in Swiss mouse assessed as mean survival time at 75 mg/kg/day, po bid administered for 9 days (Rvb = 9 days) | Influenza A virus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 15. | ALA3254580 | F | Antiviral activity against Influenza B virus Lee infected in Swiss mouse assessed as mean survival time at 75 mg/kg/day, ip bid administered for 9 days (Rvb = 11.2 days) | Influenza B virus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 16. | ALA3254581 | F | Antiviral activity against Murine hepatitis virus Friend-Braunsteiner infected in Swiss mouse assessed as mean survival time at 75 mg/kg/day, ip bid administered for 8 days (Rvb = 5.2 days) | Murine hepatitis virus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 17. | ALA3254582 | F | Antiviral activity against Murine hepatitis virus Friend-Braunsteiner infected in Swiss mouse assessed as mean survival time at 37.5 mg/kg/day, ip bid administered for 8 days (Rvb = 5.2 days) | Murine hepatitis virus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 18. | ALA3254583 | F | Antiviral activity against Murine hepatitis virus Friend-Braunsteiner infected in Swiss mouse assessed as mean survival time at 18.8 mg/kg/day, ip bid administered for 8 days (Rvb = 5.2 days) | Murine hepatitis virus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 19. | ALA3254584 | T | Toxicity in Swiss mouse | Mus musculus | 1 | ALA3244032 | organism-based format | Scientific Literature | |
| 20. | ALA3254585 | F | Antiviral activity against Murine hepatitis virus Friend-Braunsteiner infected in ip dosed Swiss mouse assessed as most effective dose administered bid for 8 days | Murine hepatitis virus | 1 | ALA3244032 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!